Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Journal of Proteome Research
|
March 16, 2021
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses
Nathan G Lawler, Nicola Gray, Torben Kimhofer, et al.
Cancer Research
|
March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells
Magali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
Nature Immunology
|
May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasin
Richard Berry, Natasha Ng, Philippa M Saunders, et al.
Clinical and Experimental Rheumatology
|
February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale
Umesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Journal of Proteome Research
|
March 16, 2021
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses
Nathan G Lawler, Nicola Gray, Torben Kimhofer, et al.
Cancer Research
|
March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells
Magali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
Nature Immunology
|
May 14, 2013
Targeting of a natural killer cell receptor family by a viral immunoevasin
Richard Berry, Natasha Ng, Philippa M Saunders, et al.
Clinical and Experimental Rheumatology
|
February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale
Umesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Page
of 5